PMID- 24493818 OWN - NLM STAT- MEDLINE DCOM- 20140418 LR - 20211021 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 192 IP - 5 DP - 2014 Mar 1 TI - Lymphatic specific disruption in the fine structure of heparan sulfate inhibits dendritic cell traffic and functional T cell responses in the lymph node. PG - 2133-42 LID - 10.4049/jimmunol.1301286 [doi] AB - Dendritic cells (DCs) are potent APCs essential for initiating adaptive immunity. Following pathogen exposure, trafficking of DCs to lymph nodes (LNs) through afferent lymphatic vessels constitutes a crucial step in the execution of their functions. The mechanisms regulating this process are poorly understood, although the involvement of certain chemokines in this process has recently been reported. In this study, we demonstrate that genetically altering the fine structure (N-sulfation) of heparan sulfate (HS) specifically in mouse lymphatic endothelium significantly reduces DC trafficking to regional LNs in vivo. Moreover, this alteration had the unique functional consequence of reducing CD8(+) T cell proliferative responses in draining LNs in an ovalbumin immunization model. Mechanistic studies suggested that lymphatic endothelial HS regulates multiple steps during DC trafficking, including optimal presentation of chemokines on the surface of DCs, thus acting as a co-receptor that may function "in trans" to mediate chemokine receptor binding. This study not only identifies novel glycan-mediated mechanisms that regulate lymphatic DC trafficking, but it also validates the fine structure of lymphatic vascular-specific HS as a novel molecular target for strategies aiming to modulate DC behavior and/or alter pathologic T cell responses in lymph nodes. FAU - Yin, Xin AU - Yin X AD - Marine Drug Research Institute, Huaihai Institute of Technology, Lianyungang 222005, China; FAU - Johns, Scott C AU - Johns SC FAU - Kim, Daniel AU - Kim D FAU - Mikulski, Zbigniew AU - Mikulski Z FAU - Salanga, Catherina L AU - Salanga CL FAU - Handel, Tracy M AU - Handel TM FAU - Macal, Monica AU - Macal M FAU - Zuniga, Elina I AU - Zuniga EI FAU - Fuster, Mark M AU - Fuster MM LA - eng GR - R01-AI37113/AI/NIAID NIH HHS/United States GR - T32HL098062/HL/NHLBI NIH HHS/United States GR - T32 HL098062/HL/NHLBI NIH HHS/United States GR - P01 HL57345-14/HL/NHLBI NIH HHS/United States GR - R21-AI102247/AI/NIAID NIH HHS/United States GR - R01 HL107652/HL/NHLBI NIH HHS/United States GR - R01 AI081923/AI/NIAID NIH HHS/United States GR - R01-HL107652-01A1/HL/NHLBI NIH HHS/United States GR - R21 AI102247/AI/NIAID NIH HHS/United States GR - R01-081923/PHS HHS/United States GR - I01 BX000987/BX/BLRD VA/United States GR - P01 HL057345/HL/NHLBI NIH HHS/United States GR - R01 AI037113/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20140203 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Chemokines) RN - 9050-30-0 (Heparitin Sulfate) SB - IM MH - Animals MH - CD8-Positive T-Lymphocytes/cytology/*immunology MH - Cell Movement/genetics/*immunology MH - Chemokines/genetics/immunology MH - Dendritic Cells/cytology/*immunology MH - Endothelium, Lymphatic/cytology/*immunology MH - Heparitin Sulfate/genetics/*immunology MH - Humans MH - Lymph Nodes/cytology/*immunology MH - Mice MH - Mice, Transgenic PMC - PMC3960083 MID - NIHMS552473 EDAT- 2014/02/05 06:00 MHDA- 2014/04/20 06:00 PMCR- 2015/03/01 CRDT- 2014/02/05 06:00 PHST- 2014/02/05 06:00 [entrez] PHST- 2014/02/05 06:00 [pubmed] PHST- 2014/04/20 06:00 [medline] PHST- 2015/03/01 00:00 [pmc-release] AID - jimmunol.1301286 [pii] AID - 10.4049/jimmunol.1301286 [doi] PST - ppublish SO - J Immunol. 2014 Mar 1;192(5):2133-42. doi: 10.4049/jimmunol.1301286. Epub 2014 Feb 3.